University Hospital
Urologic Oncology & Robotic Surgery
ISO 9001European Urology Boardda Vinci Robotic Center
✓ 24/7 ER✓ ICU✓ Insurance
Micro-PCNL / Ultra-mini PCNL
Micro-PCNL and ultra-mini PCNL are keyhole procedures that remove kidney stones through a needle- or pen-sized puncture in the back — a smaller, gentler version of standard PCNL for stones up to roughly 15–20 mm.
Content verification
Briefly about this treatment
Indications
Kidney stones up to about 15–20 mm, particularly lower-pole stones, stones that haven’t cleared with shockwave therapy (ESWL) or ureteroscopy, and residual fragments left after a previous stone procedure.
Risks
Bleeding, infection, and residual stone fragments that may need a second procedure. Risks are minimised by using the smallest effective access tract and an experienced endourology team.
Pre-procedure
CT imaging to map the stone’s size and location, standard blood work, an anaesthesia consultation, and fasting before surgery per your clinic’s protocol.
Follow-up
A follow-up ultrasound or low-dose CT a few weeks after surgery to confirm you’re stone-free, a visit to remove any stent, and longer-term monitoring if you’re prone to recurrent stones.
What is Micro-PCNL / Ultra-mini PCNL? An expert explains
Both techniques are miniaturized versions of percutaneous nephrolithotomy (PCNL) — the standard keyhole surgery for stones too large for shockwave therapy or ureteroscopy. The difference between all PCNL variants is simply the width of the access tract used to reach the stone.
Standard PCNL uses a 24–30 Fr tract and is best suited for large or staghorn stones and complex kidney anatomy. Mini-PCNL steps down to a 15–20 Fr tract for medium stones, roughly 1–2.5 cm. Ultra-mini PCNL narrows further to an 11–13 Fr tract, suited to kidney stones up to about 20 mm. Micro-PCNL uses the smallest tract of all — a 4.8–8 Fr “all-seeing needle” — for kidney stones up to about 15 mm.
(Fr = French scale, a measure of instrument diameter; a smaller number means a smaller, less invasive tract.)
Micro-PCNL was first described in 2011, using a needle just under 5 French through which both renal access and laser stone fragmentation are performed in a single step. The idea behind both techniques is the same: shrink the puncture as much as possible while still clearing the stone in one session, reducing bleeding and pain compared with standard PCNL.
Signs it may be time for Micro-PCNL / Ultra-mini PCNL
You may notice:
- Persistent or recurring flank/back pain that doesn’t settle.
- Blood in your urine, on its own or alongside stone pain.
- Repeated urinary tract infections that keep tracing back to a known stone.
- A stone that hasn’t moved or cleared despite an earlier shockwave or ureteroscopy attempt.
These signs don’t confirm a stone or a treatment path on their own — imaging and a specialist review decide that. These are the conditions linked to Micro-PCNL / Ultra-mini PCNL in the directory. Your clinician decides whether this treatment is appropriate using your symptoms, examination and test results.
- Nephrolithiasis (Kidney Stones) — Hard mineral deposits in kidneys causing pain.
- Calcium Oxalate Stones — Most common type of kidney stone.
- Uric Acid Stones — Stones formed from uric acid crystals.
- Cystine Stones — Genetic disorder causing cystine crystal stones.
- Recurrent Kidney Stones — Frequent stone formation damaging nephrons.
Remember: These entries are not a diagnosis or a treatment recommendation. Discuss your symptoms and test results with a qualified clinician.
When to consult a specialist
If you’ve had ongoing flank pain, blood in your urine, or infections that keep coming back around a known stone, it’s worth getting checked rather than waiting it out — a simple blood test, urine test, and imaging can usually tell your care team what’s going on and whether a stone needs treating at all. Most stones are manageable, and plenty don’t need surgery of any kind. If one does need removing, a urologist can tell you whether micro-PCNL or ultra-mini PCNL fits your stone.
How a session works
- Imaging and planning. Your team reviews your CT scan to map the stone’s size, location, and the safest path into the kidney.
- Anesthesia. Most patients receive general anesthesia; some centers use spinal anesthesia for shorter cases.
- Positioning. You may be positioned prone (face-down) or, in some centers, supine but tilted 10–15 degrees to raise the side being accessed.
- Percutaneous access. Using ultrasound and/or X-ray guidance, the surgeon punctures the skin over the kidney and passes a needle directly into the collecting system where the stone sits.
- Tract dilation. The needle tract is gently widened to the required size — a needle-width for micro-PCNL, or a narrow sheath (around 11–13 Fr) for ultra-mini PCNL.
- Stone fragmentation. A miniature scope is passed down the tract and a Holmium laser breaks the stone into small pieces under direct vision.
- Fragment clearance. In micro-PCNL, fragments are typically washed out through the same needle. In ultra-mini PCNL, fragments are flushed and suctioned out through the slightly wider sheath.
- Closing. A small stent may be left, a temporary drainage tube may be placed, or you may leave tubeless with just a dressing.
- Confirming clearance. Your surgeon checks with X-ray/ultrasound during the case, and a follow-up scan afterward confirms whether you’re stone-free.
Session duration
45–90 minutes
recorded for this treatment
Cost verify
$3500–$15000
indicative range
Anesthesia
General
recorded for this treatment
Remember: The exact steps, duration and preparation can vary with your indication, health and care setting. Confirm the current plan with your treating team.
Benefits
Patients and urologists choose this approach for several reasons:
- Less invasive than standard PCNL — a smaller tract means less trauma to kidney tissue.
- Lower bleeding risk — in a systematic review, the transfusion rate for micro-PCNL was under 1%, with no severe (Clavien IV–V) complications reported for either technique.
- Often a shorter hospital stay, sometimes same-day discharge, compared with standard PCNL’s typical overnight stay.
- Fewer fragments left behind than laser ureteroscopy for similarly sized stones, since pieces are actively extracted rather than left to pass.
- Good stone clearance in one session for appropriately selected stones.
Risks & side effects
The treatment has risks and trade-offs to discuss with your care team. The information below comes from this treatment data.
Bleeding, infection, and residual stone fragments that may need a second procedure are the main concerns. Also possible: injury to the kidney’s collecting system or, rarely, a nearby organ; temporary blood in the urine and flank soreness at the puncture site; and general anesthesia risks for those with heart, lung, or other chronic conditions. Risks are minimised by careful patient selection and experienced teams.
Who it may not suit: people with uncorrected bleeding disorders, an active untreated urinary tract infection, or who are pregnant are generally not candidates. These are general cautions, not a personal verdict. A qualified clinician must assess your full medical picture before recommending or delaying treatment.
What happens during & after
During: you are under anesthesia and will not feel the procedure. Vital signs and bleeding are monitored throughout. Immediately after: you’ll wake in a recovery area; mild grogginess from anesthesia, and some flank soreness or urgency to urinate, are normal. Many patients are observed for a few hours to overnight before discharge. In the following days: see the Recovery section below.
Possible complications
Most complications after micro-PCNL or ultra-mini PCNL are minor and self-limited — across reviewed studies, the majority were low-grade, with a smaller share needing an additional minor intervention, and none reaching the most serious grades. Tell your care team promptly if you develop fever, heavy bleeding, severe pain, or you cannot urinate after the procedure.
Remember:
New or severe symptoms require prompt medical advice. Do not wait for a routine appointment if you feel seriously unwell.
Recovery
First 24 hours: Many patients go home the same day or the next morning. Expect mild flank soreness, possible pink-tinged urine, and grogginess from anesthesia. Pain is usually managed with simple pain relief rather than strong opioids, given how small the access tract is.
First week: Light activity is usually fine within a few days; avoid heavy lifting, strenuous exercise, and driving until your surgeon confirms you’re ready — typically 3–7 days, but this varies. If a stent was placed, mild urgency or discomfort when urinating is common until it’s removed.
2–4 weeks: Most people return to normal activity, including work, within one to two weeks. Full internal healing of the access tract can take a little longer.
Follow-up: Your team will typically arrange imaging a few weeks after surgery to confirm you’re stone-free, and will remove any stent at a scheduled visit. Keep this appointment even if you feel well — small residual fragments aren’t always symptomatic.
Call your care team if: you develop fever, worsening (not improving) pain, heavy blood in the urine, inability to urinate, or signs of infection at the puncture site.
Clinics offering Micro-PCNL / Ultra-mini PCNL
Verified kidney centres linked to this treatment in the KidneyGlobal directory.
Academic Medical Center
Minimally Invasive Urologic Surgery
Joint CommissionNCI Cancer CenterRobotic Surgery Excellence
✓ 24/7 ER✓ ICU✓ Insurance
Specialty Hospital
Comprehensive Kidney & Urologic Care
Joint CommissionU.S. News Best HospitalCenter of Excellence
✓ 24/7 ER✓ ICU✓ Insurance
Johns Hopkins Brady Urological Institute
✓ AccreditedAcademic Medical Center
Urologic Oncology & Innovation
Joint CommissionNCI Comprehensive Cancer CenterResearch Excellence
✓ 24/7 ER✓ ICU✓ Insurance
Good questions
Most Common Questions
How long is the recovery?
Most patients return to light activities within days. Full recovery depends on the procedure and individual health; your team will provide a personalised timeline.
Is this covered by insurance?
Coverage varies by plan and country. Most major insurers cover medically necessary procedures; please confirm pre-authorisation with your insurer in advance.
What are the success rates?
When performed by experienced teams in accredited centres, success rates exceed 90% for selected indications. Your specialist can provide centre-specific outcomes.
Sources
- Mi-PCNL: A systematic review — role of minimally invasive (micro and ultra-mini) PCNL for adult urinary stone diseasePMC (National Center for Biotechnology Information)
- ‘Mini, ultra, micro’ — nomenclature and cost of new minimally invasive PCNL techniquesTherapeutic Advances in Urology
- Comparison of mini vs. standard PCNL for renal stones >2cmInternational Braz J Urol
- Ultra-Mini PCNL: A New Approach to Treating Kidney StonesMount Sinai
- Percutaneous NephrolithotomyCleveland Clinic
- Comparison of Ultra-mini PCNL and Micro PCNLClinicalTrials.gov